Match score not available

Clinical Scientist, Associate Director/Director, Breast Cancer

Remote: 
Full Remote
Contract: 
Salary: 
175 - 230K yearly
Experience: 
Senior (5-10 years)
Work from: 

Offer summary

Qualifications:

Basic Life Science degree or equivalent, At least 5 years of experience in drug development, Experience in solid tumor oncology required, Advanced degree preferred.

Key responsabilities:

  • Design and deliver clinical studies
  • Collaborate with cross-functional teams

MENARINI Group logo
MENARINI Group XLarge https://www.menarini.com
10001 Employees
See all jobs

Job description

Overview:

Clinical Scientist (Associate Director/Director), Breast Cancer
Reports to Lead Clinical Scientist, Breast Cancer
 

Founded in 1886 in Naples under the name of Farmacia Internazionale, Menarini moved in 1915 to Florence where the Group’s headquarters are still located today. High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with nearly 135 years of history. 

 

The Menarini Group is present in 70 countries and our products are sold in 140 locations around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market.

 

Thanks to the valuable contribution of around 18,000 employees, every year more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients distributed across 6 continents.

 

Menarini has made a strong commitment to oncology, investing in a pipeline of five investigational compounds for the treatment of a variety of haematological and solid tumours. The acquisition of Stemline Therapeutics in June 2020, further strengthened Menarini’s oncology portfolio, adding both commercial and clinical-stage assets. Tagraxofusp is a novel, first in class targeted therapy for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and to date, the only approved treatment for BPDCN in the U.S. and EU, and the first and only approved CD123-targeted therapy. Tagraxofusp is also being evaluated as both a single agent and in combination, in other CD123+ indications, including acute myeloid leukaemia (AML), chronic myelomonocytic leukaemia (CMML), and myelofibrosis (MF). 

 

Additionally, Menarini received exclusive rights to commercialise Selinexor for the treatment of oncology indications in the European Union and other European countries (including the United Kingdom), Latin America and other key countries. Menarini has signed an exclusive licensing agreement with Karyopharm Therapeutics for the rights to commercialise an innovative therapeutic option in Europe, Latin America, Turkey, Russia, and CIS countries. Selinexor is a first-in-class, oral Selective Inhibitor of Nuclear export compound for the treatment of hematologic cancers and solid tumours. It is already marketed in the US for multiple myeloma and is under development for solid tumour indications. Selinexor is registered in the EU for both early and late lines.

 

Menarini entered into a global licence agreement with Radius Health to complete the development of Elacestrant, an oral SERD in late-stage Phase 3 development for hormone receptor-positive advanced breast cancer. Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority review and successfully oversaw a strong launch in February to the US market with the EMA review process concluded positively in September 2023. 

 

Menarini’s commitment to oncology is also reflected in the investments made in the liquid biopsy diagnostic field through its affiliate Menarini Silicon Biosystems (MSB), a pioneer in rare cell analysis and non-invasive, advanced diagnostic solutions. MSB’s CELLSEARCH Circulating Tumour Cell (CTC) Test is the first and only clinically validated blood test cleared by the U.S. Food & Drug Administration (FDA) for detecting and counting CTCs in metastatic breast, prostate, and colorectal cancer when used in conjunction with other clinical monitoring methods.

 

Since 2021, MSB has offered in the US a menu of non-invasive Laboratory Developed Tests (LDTs) provided through its CLIA/CAP accredited US-based Lab. The services include CMC enumeration, CTC enumeration and PDL-1/HER2 biomarker and offer a minimally invasive approach to follow cancer patient’s therapeutic journey. 

 

In 2022, the company launched the CELLSEARCH® Circulating Multiple Myeloma Cell (CMMC) Enumeration LDT, the first-of-its-kind, which directly measures levels of plasma cells in the blood of patients. This test provides new, complementary information to that of the bone marrow biopsy and other standard-of-care measures. Due to its minimally invasive nature, it can be performed serially to assess plasma cell burden without requiring repeated bone marrow biopsies.

 

Menarini's vision and uniqueness in oncology is to bring together innovative therapeutic solutions and advanced liquid biopsy-based diagnostics for faster, more effective and precise patient management. 

 

It is an exciting time in the company’s development and an excellent opportunity for individuals joining us to contribute to building and shaping Menarini Stemline’s Oncology business.

Responsibilities:

Opportunity

 

The Associate Director/Director, Clinical Scientist provides scientific expertise necessary to design and deliver clinical studies. This role will provide clinical expertise and leadership in support of new product development and marketed products for the team. 

 

We are seeking an Associate Director/Director, Clinical Scientist to join our Solid Tumor Clinical Development department. This role contributes/leads to the development, evaluation, planning, and execution of clinical studies and ensures scientific integrity and interpretation of study data of a clinical development program. The Associate Director/Director, Clinical Scientist will participate in a matrix environment as part of a cross-functional team and may contribute to candidate development projects through early and/or late phase development. Reporting to the Senior Director, Clinical Scientist, this role will collaborate closely with Medical Director(s) (Directors clinical development) to provide scientific expertise necessary to design and deliver on clinical studies and/or programs.

 

Domestic and international travel may be required (approximately 5-10%)

 

Responsibilities

  • Contribute to the authoring of protocol and ICF documents/amendments, presenting to development teams and governance committees (e.g., DEC, SSC) as required.
  • Works closely with the medical monitor to assure he/she is informed of pertinent study information, including but not limited to safety and efficacy data.
  • Performs clinical/medical data review, including clinical safety monitoring and activities and procedures that ensure patient safety
  • Perform manual coding of concomitant medications and adverse events as needed.
  • Identify study and program issues by reviewing and monitoring of emerging clinical data related to safety, efficacy and PK/PD.
  • Develops sound, strategic solutions to issues and collaborates with the clinical study team to ensure issue resolution.
  • Conduct literature reviews as needed for the interpretation of study data and development of next steps.
  • Perform review, analysis, and interpretation of study results and ensure appropriate data review and accurate data reporting.
  • Collaborate with the Clinical Leader to establish and oversee the management of the study steering committee, data monitoring committee, data safety monitoring board, independent response adjudication committee, as applicable etc.
  • Write/review content for program documents, including the clinical sections of various regulatory documents such as IND, clinical study reports, investigator brochures, annual reports and updates, and clinical sections of regulatory submissions to support product approvals.
  • In conjunction with the Team Leader/Clinical Leader/CMO, develop presentations and communicate study data results to colleagues internally and to external audiences including investigators at sponsor meetings or general audiences at scientific conferences.
  • Maintain current knowledge of the external environment to ensure scientific innovations are considered and/or incorporated into clinical trial development strategy.
  • Serve as clinical science representative on cross-function teams as assigned.
Qualifications:

Skills/Knowledge

  • Demonstrated ability to review and summarize oncology study data, including experience in preparing and presenting data.
  • Thorough understanding of the oncology drug development process from pre-IND through registration and post-registration required
  • Broad understanding of drug development, including preclinical, regulatory, pharmacovigilance, drug supply, data sciences (data management, biostatistics, programming), and clinical operations (including site selection, study start-up, study conduct, and finalization) in oncology.
  • Ability to understand, interpret and communicate clinical information including literature reviews, competitive intelligence, and changing treatment paradigms in order to apply knowledge to support a robust clinical development strategy of oncology products.
  • Successful track record for the ability to interpret, analyze, and present oncology clinical data, including aggregate data analyses, in order to inform decision-making and set clinical strategy.
  • Understanding of trial design and statistics in order to apply knowledge to the design of clinical protocols.
  • Ability to work effectively in a collaborative team environment where results are achieved through influence, cooperation, and the incorporation of multiple points of view
  • Strong organization, documentation and communication skills with an ability to multitask.
  • Adaptable / flexible, willing and able to adjust to multiple demands and shifting priorities; ability to meet day-to-day challenges with confidence and professionalism

Qualifications

  • Basic Life Science degree or equivalent and at least 5 years of experience at a pharmaceutical, CRO, or biotechnology company
  • 3+ years’ experience in drug development as a clinical scientist or related role.
  • Advanced degree (e.g. MS, PharmD., PhD) or equivalent experience, is preferred
  • Experience in solid tumor oncology is required.
  • Proficient with Microsoft Word/Excel/PowerPoint, EDC systems (e.g. Medidata RAVE), and data review tools (e.g., patient profiles, report generating tools)
  • Knowledge of GCP, ICH Guidelines and current US FDA regulations. 

 

 

Menarini Stemline is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.  All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.

 

Base salary Range: $175,000-$230,000 USD

Required profile

Experience

Level of experience: Senior (5-10 years)
Spoken language(s):
English
Check out the description to know which languages are mandatory.

Other Skills

  • Adaptability
  • Teamwork
  • Communication

Administrative Director Related jobs